Sonnet biotherapeutics provides fiscal year 2022 business and financial update

Princeton, nj / accesswire / december 15, 2022 / sonnet biotherapeutics holdings, inc. (nasdaq:sonn) ("sonnet" or the "company"), a biopharmaceutical company developing innovative targeted biologic drugs, announced today its financial results for the fiscal year ended september 30th, 2022 and provided a business update. pankaj mohan, ph.d.
SONN Ratings Summary
SONN Quant Ranking